Cadrenal Therapeutics, Inc. — 10-Q Filings
9 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Cadrenal Therapeutics, Inc. (CVKD), sorted by most recent first. Each row links to the full filing on EdgarLookup. Cadrenal Therapeutics, Inc. has filed 9 10-Q documents with the SEC since 2022. To view all SEC filings by Cadrenal Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | QUARTERLY REPORT | 0001213900-25-107816 | Nov 10, 2025 | Sep 30, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-073885 | Aug 11, 2025 | Jun 30, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-040788 | May 8, 2025 | Mar 31, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-095393 | Nov 7, 2024 | Sep 30, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-066107 | Aug 7, 2024 | Jun 30, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-041014 | May 9, 2024 | Mar 31, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-084937 | Nov 9, 2023 | Sep 30, 2023 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-065223 | Aug 10, 2023 | Jun 30, 2023 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-037929 | May 10, 2023 | Mar 31, 2023 |